Sutureless Technique for Repositioning and Scleral Fixation of the Capsular Bag - Intraocular Len… (NCT07257172) | Clinical Trial Compass
RecruitingNot Applicable
Sutureless Technique for Repositioning and Scleral Fixation of the Capsular Bag - Intraocular Lens Complex With Permanent Use of Iris Retractors
Poland40 participantsStarted 2021-05-28
Plain-language summary
Sutureless technique for repositioning and scleral fixation of the capsular bag-intraocular lens complex with permanent use of iris retractors
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* only adult men and women with subluxation lens
Exclusion Criteria:
* previous ocular surgery
* Fuchs' dystrophy
* corneal haze or scarring
* history of corneal transplantation
* clinically active uveitis
* advanced glaucoma
* macular diseases that affect visual acuity (age-related macular degeneration, diabetic maculopathy)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses iris retractors permanently to hold the lens capsule in place — how does leaving those retractors in the eye long-term compare to other fixation methods my doctor might use, and what are the known risks of keeping them there permanently?
2Since this is listed as Phase NA, meaning it's a surgical technique study rather than a standard drug or device phase trial, what does that mean for how much safety and outcome data already exists for this specific sutureless approach?
3The trial is measuring best corrected visual acuity and lens position after surgery — how will my doctor know if those outcomes are on track for me, and how long would I need to be followed up to get a meaningful answer?
4My lens is subluxated, which means it has shifted out of position — are there more established surgical options my doctor would normally recommend first, and what would make this trial's technique a better fit for my specific situation?
5What kind of post-operative visits and monitoring would I need to commit to if I were to discuss enrolling in this trial, and would that be manageable given my current health and schedule?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
BCVA
Timeframe: before and 12 months after surgery
2
RE
Timeframe: 12 months after surgery
3
Position IOL
Timeframe: 1 month and 12 months after surgery
Trial details
NCT IDNCT07257172
SponsorMilitary Institute od Medicine National Research Institute